STEAP1 and non-small cell lung carcinoma: The overexpression probability of STEAP1 in normal tissues was 12.5% (5/40), which was significantly lower than that in NSCLC tissues (85.7% [221/258]), and the difference was statistically significant (P < 0.01) (Fig. 2A) (Table 2).